Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Febrile Infants without Respiratory Distress

Clinical Infectious Diseases

Volumn 71, Issue 16, 2020, Pages 2243-2245

  Paret, Michal ^a   Lighter, Jennifer ^a   Pellett Madan, Rebecca ^a   Raabe, Vanessa N ^a   Shust, Gail F ^a   Ratner, Adam J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

children; COVID 19; fever; pediatric; SARS CoV 2

Indexed keywords

AMPICILLIN; CEFEPIME; CEFTRIAXONE; VIRUS RNA;

ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CULTURE; CHILD HOSPITALIZATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CORONAVIRUS DISEASE 2019; COVID-19 TESTING; EMERGENCY WARD; ERYTHEMA; FEVER; HUMAN; INFANT; IRRITABILITY; LABORATORY TEST; MALE; NASOPHARYNGEAL SWAB; NEWBORN; PARENT; PATIENT ISOLATION; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RESPIRATORY DISTRESS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SORE THROAT; URINE CULTURE; URINE SAMPLING; VITAL SIGN; CASE REPORT; DIAGNOSIS; DYSPNEA; HOSPITALIZATION; NASOPHARYNX; NEONATAL RESPIRATORY DISTRESS SYNDROME; VIROLOGY;

COVID-19; DYSPNEA; FEVER; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; NASOPHARYNX; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SARS-COV-2;

EID: 85083865989     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciaa452     Document Type: Article

References (11)

1. 1. Wu Z, McGoogan JM. Characteristics of and important lessons from the corona-virus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention [manuscript published online ahead of print 24 February 2020]. JAMA 2020. doi:10.1001/jama.2020.2648.
2. 2. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China [manuscript published online ahead of print 16 March 2020]. Pediatrics 2020. doi:10.1542/peds.2020-0702.
3. 3. Liu W, Zhang Q, Chen J, et al. Detection of Covid-19 in children in early January 2020 in Wuhan, China. N Engl J Med 2020; 382:1370-1.
4. 4. Centers for Disease Control and Prevention COVID-19 Response Team. Coronavirus disease 2019 in children-United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:422-6.
5. 5. Xu Y, Li X, Zhu B, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med 2020; 26:502-5.
6. 6. Aronson PL, Shabanova V, Shapiro ED, et al. A prediction model to identify febrile infants 60 days at low risk of invasive bacterial infection. Pediatrics 2019; 144. doi:10.1542/peds.2018-3604.
7. 7. Nicholson EG, Avadhanula V, Ferlic-Stark L, Patel K, Gincoo KE, Piedra PA. The risk of serious bacterial infection in febrile infants 0-90 days of life with a respiratory viral infection. Pediatr Infect Dis J 2019; 38:355-61.
8. 8. Centers for Disease Control and Prevention. Discontinuation of transmission-based precautions and disposition of patients with COVID-19 in healthcare settings (interim guidance). Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-hospitalized-patients.html. Accessed 25 March 2020.
9. 9. Assiri A, McGeer A, Perl TM, et al; KSA MERS-CoV Investigation Team. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013; 369:407-16.
10. 10. McDonald LC, Simor AE, Su IJ, et al. SARS in healthcare facilities, Toronto and Taiwan. Emerg Infect Dis 2004; 10:777-81.
11. 11. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [manuscript published online ahead of print 7 February 2020]. JAMA 2020. doi:10.1001/jama.2020.1585.